These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23920125)

  • 21. The nucleolar protein GLTSCR2 is required for efficient viral replication.
    Wang P; Meng W; Han SC; Li CC; Wang XJ; Wang XJ
    Sci Rep; 2016 Nov; 6():36226. PubMed ID: 27824081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death.
    Yim JH; Kim YJ; Ko JH; Cho YE; Kim SM; Kim JY; Lee S; Park JH
    Cell Death Differ; 2007 Nov; 14(11):1872-9. PubMed ID: 17657248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
    Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells.
    Lui K; Huang Y; Choi HL; Yu S; Wong KB; Chen S; Chan FL
    Prostate; 2006 Nov; 66(15):1600-19. PubMed ID: 16927302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
    Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
    Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipofuscin pigment can be used as a prognostic marker in prostatic adenocarcinoma.
    Mahmoodi M; Zhang S; Salim S; Hou JS; Garcia FU
    Ann Diagn Pathol; 2006 Oct; 10(5):257-62. PubMed ID: 16979516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
    Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
    Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cancer of the prostate: evaluation of the expression of the mutated protein of the 53 tumor suppressor gene].
    Rivera P; Ibacache G; García M; Roa I; Orio M
    Actas Urol Esp; 1997 Oct; 21(9):822-6. PubMed ID: 9471864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.
    Girinsky T; Koumenis C; Graeber TG; Peehl DM; Giaccia AJ
    Cancer Res; 1995 Sep; 55(17):3726-31. PubMed ID: 7543816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
    Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
    Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
    Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G
    Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
    Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
    Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
    Liu R; Zhang Z; Xu Y
    Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.